Saturday, August 18, 2018
 
 
Company News: Page (1) of 1 - 07/17/18 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
Trivedi Global, Inc. and Joy Angevin Balmer Announce the Research Results of a Biofield Energy Treated Nutraceutical for Reducing Inflammatory and Autoimmune Disorders
 
(July 17, 2018)
Trivedi Global, Inc. and Joy Angevin Balmer Announce the Research Results of a Biofield Energy Treated Nutraceutical for Reducing Inflammatory and Autoimmune Disorders

Joy Angevin Balmer, an evidence-based healer, today announces the impact of a biofield energy treated proprietary nutraceutical to combat inflammation and autoimmune disorders.

The preclinical research assessed biomarkers for systemic and organ-specific inflammation, as well as, immune function response. The following data was reported:

  • Over 70% decrease in Interleukin (IL-1?) expression
  • Over 30% decrease in Macrophage Inflammatory Protein (MIP-1?)



The results of this holistic healing-based approach show benefits in managing stress and anti-aging. Additionally, the research suggests the nutraceutical's potential to fight against inflammation, with a safe therapeutic index.

These findings are promising, whereas inflammation and stress are known contributors to many of today's most common diseases. Furthermore, through improving these areas, this supplement also has the potential to impact one's overall health and quality of life.

Overall this nutraceutical shows great promise as a complementary and alternative medicine supplement to combat autoimmune diseases and inflammatory disorders. Some disorders may include Celiac Disease (gluten-sensitive enteropathy), Irritable Bowel Syndrome (IBS), Parkinson's Disease, Graves' Disease, chronic peptic ulcers, Hepatitis, Addison's Disease, Multiple Sclerosis (MS), Tuberculosis, Rheumatoid arthritis, Chronic periodontitis, Crohn's disease, Ulcerative colitis, Lupus, Vitiligo, Hashimoto Thyroiditis, Chronic sinusitis, Type 1 Diabetes, Asthma, Rheumatoid Arthritis, Sjogren Syndrome, Alopecia Areata, Dermatitis, Psoriasis, Fibromyalgia, Diverticulitis, Chronic Fatigue Syndrome, Alzheimer's Disease, Atherosclerosis and more. Additionally, the nutraceutical shows promise in the prevention of immune-mediated tissue damage in cases of organ transplants.

Balmer provided this Biofield Energy Healing Treatment as part of a group of seven energy healers. Six were remotely located in the U.S.A and one in Canada. The test formulation was located in the research laboratory of Dabur Research Foundation, near New Delhi, India. The Biofield Energy Treatment was administered for 5 minutes through the healers' unique Energy Transmission process remotely to the test samples under laboratory conditions. Balmer, as well as, the other six biofield healers participating in this research never visited the laboratory in person, nor had any contact with the nutraceutical samples.

About Biofield Energy Treatments
The National Center of Complementary and Integrative Health (NCCIH) has recognized and accepted Biofield Energy Healing Treatments as a complementary and alternative medicine (CAM) health care approach in addition to other therapies, medicines, and practices. CAM therapies have been practiced worldwide with reported clinical benefits in different health disease profiles. Human Biofield Energy has subtle energy that has the capacity to work in an effective manner. This energy can be harnessed and transmitted by the gifted into living and non-living things via the process of a Biofield Energy Healing Treatment or Therapy.

Scientific Publications

Title: Evaluation of Pro-Inflammatory Cytokines Expression in Mouse Splenocytes After Incubation with Biofield Treated Herbomineral Formulation: Effect of Biofield Energy
Healing Treatment - The Trivedi Effect®
Journal: American Journal of Biomedical and Life Sciences

Published: December 8, 2016

URL: https://www.trivedieffect.com/the-science/publications/nutraceuticals-publications/evaluation-of-pro-inflammatory-cytokines-expression-in-mouse-splenocytes-after-incubation-with-biofield-treated-herbomineral-formulation-effect-of-biofield-energy-healing-treatment-the-trivedi-effect/

About Joy Angevin Balmer

Joy Angevin Balmer is an evidence-based energy healer validated by scientific research. Balmer, a former educator for more than 30 years, created a very successful Home School Assistance Program and worked with students of all ages and in all areas of instruction. She has a deep belief in the power of education coupled with an understanding that only through connection to the Divine can people reach their highest potential. Balmer sought ways to integrate traditional education with holistic healing and the spiritual journey.

Then in 2010 when Balmer met Guruji Mahendra Trivedi, founder of Trivedi Global, Inc. and the Trivedi Effect®, she experienced profound personal transformation on all levels. She was inspired to join the Trivedi Healers Mastery program where under the guidance of Guruji Trivedi her natural healing gifts blossomed. Inspired, she retired from her Home-Schooling Program in 2014 to become a spiritual holistic medicine-based healer. The impact of Balmer's Biofield energy healing abilities on overall health, improved quality of life, and increased Vitamin D3 absorption have been validated by the rigor of internationally accepted models of scientific research and published in multiple peer-reviewed scientific journals.

http://www.joyblessings.com

About Guruji Mahendra Trivedi & The Trivedi Effect®
Guruji Mahendra Kumar Trivedi, the founder of the Trivedi Effect®, is on a mission to usher in a new era that integrates science, spirituality, and consciousness to vastly improve the human condition and benefit humanity on a global scale. To date, more than 250,000 people worldwide have benefited from the Trivedi Effect®. His organization, Trivedi Global, Inc., is collaborating with globally renowned product research and development organizations to bring to market proprietary products and therapies in the areas of nutraceuticals, pharmaceuticals, and more. Alice Branton, CEO, Trivedi Global, Inc., recently spoke on the impact of the Trivedi Effect® at the Entrepreneurship Club of the Harvard Business School, Nasdaq, Microsoft, and Coca-Cola. She also appeared on more than 35 network television news shows in the last year including ABC, NBC, FOX, CW and more. Dahryn Trivedi, a prodigious spiritual leader, young entrepreneur, inspiring speaker and paradigm-shifting scientist also joins in the mission.

The Trivedi Effect® is an evidence-based phenomenon in which an individual can harness inherently intelligent energy from nature and transmit it to living organisms and non-living materials, anywhere in the world through thought intention, to significantly enhance potency and beneficially alter their characteristics and behaviors through transformation at the atomic, molecular, and cellular levels.

The Trivedi Effect® has been tested, measured, and validated in over 4,000 scientific experiments globally, by world-renowned scientists and research institutes using the rigor of internationally accepted models of scientific research with the most sophisticated technologies available on this planet. Challenging the known frontiers of science, this research has resulted in over 350 publications in major international peer-reviewed scientific journals with over 4,000 citations.

These publications are available in over 3,500 universities internationally including the prestigious Ivy League Universities, as well as, the National Institutes of Health (NIH).
http://www.TrivediEffect.com

Forward-Looking Statements
This press release contains forward-looking statements. Forward-looking statements involve known and unknown risks and uncertainties, which may cause actual results in future periods to differ materially from stated results. Readers are cautioned that forward-looking statements are not guarantees of future performance or events and, accordingly, are cautioned not to put undue reliance on forward-looking statements due to the inherent uncertainty of such statements. Statements in this news release that are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations, and orientations regarding the future. Often, but not always, forward-looking statements can be identified by words such as “may", “will", “should", “would", “expect", “intend", “plan", “anticipate", “believe", “estimate", “predict", “potential", “seem", “seek", “future", “continue", “appear", or variations of such words including negative variations thereof, and phrases that refer to certain actions, events or results that may, could, would, might or will occur or be taken or achieved.

Media Contacts
Joy Angevin Balmer
(575) 342-1373
[email protected]

Alice Branton,
Chief Executive Officer
Trivedi Global, Inc.
(702) 907-8864
[email protected]

Read the full story at https://www.prweb.com/releases/2018/07/prweb15614782.htm.


Page: 1


Related Keywords:
Related Sites: AEC Newsroom ,   Digital CAD ,   DMN Newswire ,   HTN - Health Technology Net
Related Newsletter: CADList Newsletter ,   Tutorial Finder ,   Review Seeker
 
 
 
 
 
 
 
Seniors

Drugs
  • Neurovascular Devices Market High Revenue at USD 24,650 mn by 2023 | Therapeutic Application Hemorrhagic & Ischemic Strokes | Worldwide Segmentation by MRFR
  • The Alzheimer's Research and Prevention Foundation (ARPF) Announces Second Brain Longevity® Therapy Training Program in Washington D.C.
  • Image Guided Radiotherapy Market to Experience Unfaltering Growth at 15.8% CAGR to Revolutionize the Healthcare Sector by 2023
  • Disposable Negative Pressure Wound Therapy Devices Market: Global Industry Analysis (2012 - 2016) & Opportunity Assessment (2017 - 2027)
  • Elysium Health™ Announces Exclusive License for Use of Nicotinamide Riboside for the Slowing of Aging and Prevention of Age-Related Diseases from Mayo Clinic and Harvard

    Cancer
  • Biotest AG: Cytotect(R) CP prevents transmission of Cytomegalovirus (CMV) to the unborn baby in pregnant women who are infected with CMV for the first time
  • ViewRay Announces Full Exercise of Underwriters' Option to Purchase Additional Shares and Closing of Public Offering of Common Stock
  • Mirati Therapeutics Announces Presentation Of KRAS G12C Chemistry Advances At The 255th American Chemical Society (ACS) National Meeting And Exposition
  • Agenus Receives Second Milestone Payment from Merck
  • Colorado Pain Care Broadens Practice to Include Cancer Patient Treatment in Denver, CO and Surrounding Area
  •  
     
     
     
     
     





    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines